Responses seen with personalized neoantigen peptide vaccine in NSCLC patients with EGFR mutations July 27, 2021
Leo Pharma begins phase IIa study of LEO-138559 for moderate to severe atopic dermatitis July 27, 2021
Cerecor reports initial phase Ib data on CERC-002 in moderate to severe Crohn's disease July 27, 2021
RSS